23 May 2013
Keywords: merck, co, propecia, shows, promise, hair, loss
Article | 26 March 1997
Data from Phase III clinical trials with Merck & Co's Propecia(finasteride 1mg), an oral treatment for male pattern hair loss, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 March 1997
22 May 2013
© 2013 thepharmaletter.com